Halozyme Therapeutics, Inc. (HALO) Posts Q1 Loss of 17c/Share

May 8, 2013 5:21 PM

Halozyme Therapeutics, Inc. (NASDAQ: HALO) reported Q1 EPS of ($0.17) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found